NOSGX
Price
$20.57
Change
-$0.88 (-4.10%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

NOSGX vs VSIAX

Header iconNOSGX vs VSIAX Comparison
Open Charts NOSGX vs VSIAXBanner chart's image
Northern Small Cap Value
Price$20.57
Change-$0.88 (-4.10%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
NOSGX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NOSGX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NOSGX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. NOSGX (988M). VSIAX pays higher dividends than NOSGX: VSIAX (2.01) vs NOSGX (1.41). NOSGX was incepted earlier than VSIAX: NOSGX (31 years) vs VSIAX (13 years). VSIAX is a more actively managed with annual turnover of: 16.00 vs. NOSGX (13.25). NOSGX has a lower initial minimum investment than VSIAX: NOSGX (2500) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. NOSGX (6.91). VSIAX return over 5 years is better than : 52.83 vs. NOSGX (8.41).
NOSGXVSIAXNOSGX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years13 years-
Gain YTD10.11315.03167%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets988M63B2%
Annual Yield % from dividends1.412.0170%
Returns for 1 year6.9116.2343%
Returns for 3 years7.4120.6736%
Returns for 5 years8.4152.8316%
Returns for 10 years11.14105.6511%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics